Page 219 - புளோரிடா அட்லாண்டிக் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol To properly monitor and help curb the spread of COVID-19, several millions of diagnostic tests are required daily in just the United States alone. There is still a widespread lack of COVID-19 testing in the U.S. and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. The current gold standard for COVID-19 diagnostic testing in the U.S., developed by the U.S. Centers for Disease Control and Prevention (CDC), is quantitative PCR-based (qPCR) molecular tests that detect the presence of the viral nucleic acid. Although highly accurate, these CDC-approved tests require specialized reagents, equipment, and personnel training. In addition, multiple diagnostic kits that have been rapidly developed and introduced into the market have accuracy, cost and distribution limitations. Moreover, the test systems currently utilize

United statesJanet robishawMassimo caputiEmily hendersonFlorida atlantic university schmidt college of medicineUs centers for diseaseSchmidt college of medicineDepartment of biomedical scienceDisease controlFlorida atlantic universitySchmidt collegeLead authorBiomedical scienceClinical diagnosticsHealth careMolecular biology